Understanding the behavior of nano-particles in biological systems opens up entirely new possibilities for medical treatment.
Both the targeted interaction between nano-particles and cells (chemical reactive interface) and the dispersibility of nano-particles in liquids are all to do with surfaces.
Plasmatreat has developed appropriate plasma reactors with continuous particle delivery for plasma pre-treatment of nano-particles. One particular challenge in this is preventing agglomeration of nano-particles (nano-powder).
Thanks to the eddy current principle used, it is possible to very evenly feed nano-particles into the plasma so as to ensure a continuous, reproducible process.